Literature DB >> 11238892

Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

A Seluanov1, V Gorbunova, A Falcovitz, A Sigal, M Milyavsky, I Zurer, G Shohat, N Goldfinger, V Rotter.   

Abstract

The cellular function of p53 is complex. It is well known that p53 plays a key role in cellular response to DNA damage. Moreover, p53 was implicated in cellular senescence, and it was demonstrated that p53 undergoes modification in senescent cells. However, it is not known how these modifications affect the ability of senescent cells to respond to DNA damage. To address this question, we studied the responses of cultured young and old normal diploid human fibroblasts to a variety of genotoxic stresses. Young fibroblasts were able to undergo p53-dependent and p53-independent apoptosis. In contrast, senescent fibroblasts were unable to undergo p53-dependent apoptosis, whereas p53-independent apoptosis was only slightly reduced. Interestingly, instead of undergoing p53-dependent apoptosis, senescent fibroblasts underwent necrosis. Furthermore, we found that old cells were unable to stabilize p53 in response to DNA damage. Exogenous expression or stabilization of p53 with proteasome inhibitors in old fibroblasts restored their ability to undergo apoptosis. Our results suggest that stabilization of p53 in response to DNA damage is impaired in old fibroblasts, resulting in induction of necrosis. The role of this phenomenon in normal aging and anticancer therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238892      PMCID: PMC86701          DOI: 10.1128/MCB.21.5.1552-1564.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

Review 1.  Acid-induced denaturation of DNA in situ as a probe of chromatin structure.

Authors:  Z Darzynkiewicz
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

2.  Increased p53 protein associated with aging in human diploid fibroblasts.

Authors:  K S Kulju; J M Lehman
Journal:  Exp Cell Res       Date:  1995-04       Impact factor: 3.905

Review 3.  Anatomical methods in cell death.

Authors:  J F Kerr; G C Gobé; C M Winterford; B V Harmon
Journal:  Methods Cell Biol       Date:  1995       Impact factor: 1.441

4.  Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved.

Authors:  E Wang
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

5.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

6.  Investigation of the role of G1/S cell cycle mediators in cellular senescence.

Authors:  C A Afshari; P J Vojta; L A Annab; P A Futreal; T B Willard; J C Barrett
Journal:  Exp Cell Res       Date:  1993-12       Impact factor: 3.905

7.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Authors:  A Di Leonardo; S P Linke; K Clarkin; G M Wahl
Journal:  Genes Dev       Date:  1994-11-01       Impact factor: 11.361

8.  Escape from senescence in human diploid fibroblasts induced directly by mutant p53.

Authors:  J A Bond; F S Wyllie; D Wynford-Thomas
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

9.  Renal tolerance of cisplatin in patients more than 80 years old.

Authors:  A Thyss; L Saudes; J Otto; A Creisson; M H Gaspard; O Dassonville; M Schneider
Journal:  J Clin Oncol       Date:  1994-10       Impact factor: 44.544

10.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  47 in total

1.  Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells.

Authors:  Anna E Vilgelm; Jeff S Pawlikowski; Yan Liu; Oriana E Hawkins; Tyler A Davis; Jessica Smith; Kevin P Weller; Linda W Horton; Colt M McClain; Gregory D Ayers; David C Turner; David C Essaka; Clinton F Stewart; Jeffrey A Sosman; Mark C Kelley; Jeffrey A Ecsedy; Jeffrey N Johnston; Ann Richmond
Journal:  Cancer Res       Date:  2014-11-14       Impact factor: 12.701

Review 2.  The immune system in the elderly: activation-induced and damage-induced apoptosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Daniela Monti; Claudio Franceschi
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein BCL-xL.

Authors:  Patrick J Rochette; Douglas E Brash
Journal:  Mech Ageing Dev       Date:  2008-01-04       Impact factor: 5.432

4.  Senescent keratinocytes die by autophagic programmed cell death.

Authors:  Karo Gosselin; Emeric Deruy; Sébastien Martien; Chantal Vercamer; Fatima Bouali; Thibault Dujardin; Christian Slomianny; Ludivine Houel-Renault; Fazia Chelli; Yvan De Launoit; Corinne Abbadie
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

5.  Distinct roles for p107 and p130 in Rb-independent cellular senescence.

Authors:  Brian D Lehmann; Adam M Brooks; Matthew S Paine; William H Chappell; James A McCubrey; David M Terrian
Journal:  Cell Cycle       Date:  2008-03-07       Impact factor: 4.534

Review 6.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

Review 7.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

8.  Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3.

Authors:  Baoying Huang; Lyubomir T Vassilev
Journal:  Aging (Albany NY)       Date:  2009-09-25       Impact factor: 5.682

9.  Awakening p53 in senescent cells using nutlin-3.

Authors:  Thaddeus T Schug
Journal:  Aging (Albany NY)       Date:  2009-10-13       Impact factor: 5.682

10.  The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.

Authors:  John P Alao; Per Sunnerhagen
Journal:  Radiat Oncol       Date:  2009-11-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.